Гигантоклеточный артериит. Часть I. Терминология, классификация, клинические проявления, диагностика
https://doi.org/10.14412/1996-7012-2012-741
Аннотация
Литература
1. <div><p>Баранов А.А. Рекомендации по ведению больных васкулитами (по материалам рекомендаций Европейской антиревматической лиги). Совр. ревматол. 2009; 2: 5—9.</p><p>Eberhardt R.T., Dhadly M. Giant cell arteritis: diagnosis, management, and cardiovascular implications. Cardiol Rev 2007; 15: 55—61.</p><p>Бунчук Н.В. Ревматические заболевания пожилых. М.: МЕДпресс-информ, 2010: 6—86.</p><p>Unwin B., Williams C.M., Gilliland W. Polymyalgia rheumaticа and giant cell arteritis. Am Fam Physician 2006; 74: 1547—54.</p><p>Hunder G.G. Epidemiology of giant cell arteritis. Cleve Clin J Med 2002; 69(Suppl. 2): SII79—SII82.</p><p>Gonzalez-Gay M.A., Vazquez-Rodriguez T.R., Lopez-Diaz M.J. et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthr Car Res 2009; 61(10): 1454—61.</p><p>Salvarani C., Cantini F., Bolardi L. et al. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261 —71.</p><p>Gabriel S.E., Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthr Res Ther 2009; 11: 229doi: 10.1186/ar2669.</p><p>Smith C.A., Fidler W.J., Pinals R.S. The epidemiology of giant cell arteritis: report of a ten-year study in Shelby County, Tennessee. Arthr Rheum 1983; 26: 1214—9.</p><p>Boesen P., Sorensen S.F. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation 1982—1985. Arthr Rheum 1987; 30: 294—9.</p><p>Weyand C.M., Ma-Krupa W., Goronzy J.J. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 2004; 3: 46—53.</p><p>Schett G., Winkler S., Hollenstein U. et al. Obstruction of the pulmonary artery by granulomatous vasculitis: a clinical, morphological, and immunological analysis. Ann Rheum Dis 2002; 61(5): 463—7.</p><p>Assie C., Marie I. Giant cell arteritis -related upper/lower limb vasculitis. Presse Med 2011; 40(2): 151—61.</p><p>Poller D., Wyk Q., Jeffrey M. The importance of skip lesions in temporal arteritis. J Clin Pathol 2000; 53(2): 137—9.</p><p>Zenone T., Puget M. Dry cough is a frequent manifestation of giant cell arteritis. Rheumatol Int 2012. [Epub ahead of print].</p><p>Kumar A., Costa D.D. Insidious posterior circulation stroke with rapid deterioration due to vertebral giant cell arteritis. Age Ageing 2007; 36: 695—7.</p><p>Gil H., Mauny F., Meaux-Ruault N. et al. Usefulness of antineutrophil cytoplazmic antibodies in giant cell arteritis. Rev Med Int 2008; 29(10): 780-4.</p><p>Emilie D., Liozon E., Crevon M.C. et al. Production of interleukin 6 by granulomas of giant cell arteritis. Hum Immunol 1994; 39: 17—24.</p><p>Roche N.E., Fulbright J.W., Wagner A.D. et al. Correlation of interleukin-6 production and disease activity in polymyalgia rheumati-ca and giant cell arteritis. Arthr Rheum 1993; 36: 1286—94.</p><p>Park M.C., Lee S.W., Park Y.B. et al. Serum cytokine profiles and their correlations with disease activity in Takayasu’s arteritis. Rheumatology 2006; 45: 545—8.</p><p>Nishimoto N., Nakahara H., Yoshio-Hoshino N. et al. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthr Rheum 2008; 58: 1197—200.</p><p>Visvanathan S., Rahman M.U., Hoffman G.S. et al. Cid Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis — a prospective longitudinal study. Rheumatology (Oxford) 2011; 50(11): 2061—70.</p><p>Banks P.M., Cohen M.D., Ginsburg W.W. et al. Immunohistologic and cytochemical studies of temporal arteritis. Arthr Rheum 1983; 10: 1201 —7.</p><p>Cid M.C., Campo E., Ercilla G. et al. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthr Rheum 1989; 32: 884—93.</p><p>Martinez-Taboada V.M., Alvarez L., RuizSoto M. et al. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008; 44: 207—20.</p><p>Herrandez-Rodriguez J., Garcia-Martinez A., Casademont J. et al. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthr Rheum 2002; 47: 29—35.</p><p>Hernandez-Rodriguez J., Segarra M., Vilardell C. et al. Tissue production of pro-inflammatory cytokines (IL-1β, TNFα and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements of giant cell arteritis. Rheumatology 2004; 43: 294—301.</p><p>Cid M.C., Hoffman M.P., Hernandez-Rodriguez J. et al. Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis. Rheumatology 2006; 45: 1356—63.</p><p>Nir-Paz R., Gross A., Chajek-Shaul T. Reduction of jaw opening (trismus) in giant cell arteritis. Ann Rheum Dis 2002; 61(9): 832—33. doi: 10.1136/ard.61.9.832.</p><p>Weyand C.M., Goronzy J.J. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003; 139: 505—15.</p><p>Gonzales-Gay M.A., Blanco R., Rodriguez-Valverde V. et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthr Rheum 1998; 41: 1497—504.</p><p>Rahman W., Rahman F.Z. Major review — giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol 2005; 50: 415—28.</p><p>Sandercock P.A., Warlow C.P., Jones J.N. et al. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. BMJ 1989; 298: 75—80.</p><p>Hayreh S.S., Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 2003; 217: 239—59.</p><p>Birkhead N.C., Wagener H.P., Schick R.M. Treatment of temporal arteritis with adrenal corticosteroids: results in 55 cases in which lesion was proven at biopsy. JAMA 1958; 163: 821—7.</p><p>Hayreh S.S., Podhajsky R.A., Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998; 125: 521—6.</p><p>Lee A., Luk A., Phillips K.R. et al. Giant cell aortitis: a difficult diagnosis assessing risk for the development of aneurysms and dissections. Cardiovasc Pathol 2011. Epub ahead of print.</p><p>Национальное руководство по ревматологии. Под ред. Е.Л. Насонова, В.А. Насоновой. М.: ГЭОТАР-Медиа, 2008; 565—7.</p><p>Hunder G.G., Bloch D.A., Michel B.A. et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthr Rheum 1990; 33: 1122—8.</p><p>Melson M., Weyand C., Newman N.J. et al. The diagnosis of giant cell arteritis. Rev Neurol Dis 2007; 4: 128—42.</p><p>Medeiros D.A., Miguel E. A ecographia doppler com cor no diagnostico da arterite das celulas gigantes / Orgao Oficial Da Socidada Portuguesa De Reumatologia. Acta Reumatol Port 2009; 34: 183—9.</p><p>Suelves A.M., Espana-Gregori E., Tembl J. et al. Doppler ultrasound and giant cell arteritis. Clin Ophthalmol 2010; 4: 1383—4.</p><p>Blockmans D., de Ceuninck L., Vanderschueren S. et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthr Rheum 2006; 55: 131—7.</p><p>Gonzalez S.O., Arriaga B.A., Cabeza M.A. et al. Rare complication in a patient with giant cell arteritis. An Sist Sanit Navar 2010; 33(3): 327—30.</p><p>Weyand C.M., Goronzy J.J. Medium-and large-vessel vasculitis. N Engl J Med 2003; 349: 160—9.</p><p>Achkar A.A., Lie J.T., Hunder G.G. et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Int Med 1994; 120: 987—92.</p><p>Mukhtyar C., Guilevin L., Cid M.C. et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 3: 318—23.</p></div><br />
Рецензия
Для цитирования:
Сатыбалдыев А.М. Гигантоклеточный артериит. Часть I. Терминология, классификация, клинические проявления, диагностика. Современная ревматология. 2012;6(3):23-27. https://doi.org/10.14412/1996-7012-2012-741
For citation:
Satybaldyev A.M. Giant cell arteritis. Part I. Terminology, classification, clinical manifestations, diagnosis. Modern Rheumatology Journal. 2012;6(3):23-27. (In Russ.) https://doi.org/10.14412/1996-7012-2012-741
Просмотров: 1397
Послать статью по эл. почте 